PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31614510-7	2019	According to the molecular docking prediction, flumequine targeted dual-specificity MAPK phosphatase 16 (DUSP16), which is a major negative regulator of p38 MAPK and JNK.	flumequine	47-57	dual specificity phosphatase 16	Mus musculus	67-103	
31614510-7	2019	According to the molecular docking prediction, flumequine targeted dual-specificity MAPK phosphatase 16 (DUSP16), which is a major negative regulator of p38 MAPK and JNK.	flumequine	47-57	dual specificity phosphatase 16	Mus musculus	105-111